Novo Nordisk A/S, the world's largest maker of insulin, reported fourth-quarter earnings that missed analysts estimates as sales of its key diabetes drug Victoza rose less than expected. Profit rose to 8.26 billion kroner ($1.21 billion), the ... Bloomberg, 1 week ago
Novo Nordisk Fourth-Quarter Profit Misses Estimates on Victoza - La Repubblica, 1 week ago
1 images for "Victoza"
VANCOUVER, Canada , Dec. 2, 2015 /PRNewswire/ — New findings from a network meta-analysis show that treatment with Victoza® (liraglutide) provides a greater HbA1c reduction and an improved likelihood of reaching glycaemic goals compared to ...PharmaVOICE, 2 months ago BRIEF-Novo Nordisk presents new Victoza, Ryzodeg results Reuters UK, 2 months ago Novo Nordisk says Victoza provides greater HbA1c reductions than SGLT2 inhibitors FirstWord Pharma, 2 months ago Victoza® (liraglutide) provides greater glycaemic control than SGLT-2 inhibitors Ulitzer, 2 months ago
Researchers found that Victoza successfully reduced BMI, cholesterol-low density lipoprotein and other clinical variables in patients with nonalcoholic steatohepatitis, according to data published in the Journal of Hepatology . Liraglutide ...Orthopedics Today, 1 day ago
Novo Nordisk is striking back against the SGLT2 drug class. Maker of the blockbuster GLP-1 diabetes drug Victoza, Novo rolled out a new meta-analysis showing that its med beat those in the other class at reducing the blood sugar metric HbA1c.FiercePharmaMarketing, 2 months ago Novo touts SGLT2-topping data for blockbuster Victoza FiercePharma, 2 months ago Novo Nordisk buys Xoma diabetes program and scores trial successes Pharmafile, 2 months ago Novo Nordisk Takes NASH Treatment Another Step Forward Seeking Alpha, 1 week ago
Novo Nordisk announced Wednesday that fourth-quarter profit reached 8.3 billion kroner ($1.2 billion), up 26 percent year-over-year, although the figure fell short of analyst estimates of 8.5 billion kroner ($1.2 billion). Sales in the three-month ...FirstWord Pharma, 1 week ago
Liraglutide is a drug used to lower blood sugar levels for people with type 2 diabetes. However, a new study suggests that long-term use of the medication may do just the opposite. Long-term liraglutide use may increase blood sugar levels rather ...Medical News Today, 4 hours ago Medical Information In the present day: Sort 2 diabetes: lengthy-time period liraglutide use might increase blood sugar ranges 9ija News.com, 5 hours ago Popular Diabetes Drug Found To Lose Its Effectiveness Over Time Medical Daily, 14 hours ago
When Pharmabro Martin Shkreli appeared before a House Committee meeting last week and took the fifth, he was soundly mocked. And so would I have been, had I appeared instead. You can believe that if I am ever subpoenaed for any reason, I will answer ...Daily Kos, 13 hours ago
Dive Brief: Novo Nordisk had a slightly weaker quarter than expected, due in large part to the competitive impact of Eli Lilly's Trulicity entering the market.Overall Q4 2015 profit was up 26% to 8.26 billion kroner—but less than analysts had ...BioPharma Dive, 1 day ago Sanofi (SNY) Olivier Brandicourt on Q4 2015 Results - Earnings Call Transcript Seeking Alpha, 2 days ago How Novo's Diabetes and Obesity Care Segment Performed in 4Q15 Yahoo! Finance, 3 days ago Why Novo Nordisk Fell after Its 4Q15 Earnings Release Yahoo! Finance, 3 days ago
More from: , Pharma Letter...and 5 other sources
LONDON, Feb. 10, 2016 /PRNewswire/ -- How loyal are doctors to your Type 2 Diabetes Mellitus (T2DM) brand? How many other brands do they recommend? Which ones? What can you do to set your brand apart and win more market share? Get the answers in ...TickerTech.com, 1 day ago
Asia-Pacific Type 2 Diabetes Mellitus Therapeutics Markets to 2021 Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia high blood glucose levels that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated ...Before It's News, 4 days ago Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Tutorial Finder, 1 day ago
on your WebpageAdd Widget >Get your members hooked!